ZIOPHARM Oncology, Inc. (ZIOP)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
5.62-0.21 (-3.60%)
As of 1:44 PM EDT. Market open.
People also watch:
XONHALOKITECLDXJUNO
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open5.78
Prev Close5.83
Bid5.64 x 5400
Ask5.65 x 1400
Day's Range5.62 - 5.85
52wk Range4.45 - 14.93
1y Target EstN/A
Market Cap733.39M
P/E Ratio (ttm)-4.28
Beta1.91
Volume585,414
Avg Vol (3m)2,266,928
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • ZIOPHARM Oncology, Inc. breached its 50 day moving average in a Bullish Manner : ZIOP-US : August 16, 2016
    Capital Cube8 days ago

    ZIOPHARM Oncology, Inc. breached its 50 day moving average in a Bullish Manner : ZIOP-US : August 16, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for ZIOPHARM Oncology, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving ... Read more (Read more...)

  • Capital Cube9 days ago

    ETF’s with exposure to ZIOPHARM Oncology, Inc. : August 15, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to ZIOPHARM Oncology, Inc. Here are 5 ETF’s with the largest exposure to ZIOP-US. Comparing the performance and risk of ZIOPHARM Oncology, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • ZIOPHARM Oncology, Inc. :ZIOP-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016
    Capital Cube12 days ago

    ZIOPHARM Oncology, Inc. :ZIOP-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016

    Categories: Yahoo Finance Click here to see latest analysis ZIOPHARM Oncology, Inc. reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of ZIOPHARM Oncology, Inc. – CytRx Corporation, Amgen Inc., TESARO, Inc., Threshold Pharmaceuticals, Inc., Kite Pharma, Inc., Nutraceutical International Corporation, Bristol-Myers Squibb Company, Intrexon Corporation and Quintiles ... Read more (Read more...)